Cold Sore Virus Approved By Fda To Effectively Treat Melanoma Cancer Kutv A recent phase i study led by the perlmutter cancer center at nyu langone health is one of the first to show how oncolytic viruses, viruses that infect and break down cancer cells but not normal cells, can be used to boost already approved cancer therapies. This study found that ce1, a protein segment found on common cold viruses such as enteroviruses and rhinoviruses, can activate certain immune cells that are also involved in robust anti cancer responses.
Can A Cold Virus Treat Cancer The findings suggest how respiratory virus infections may contribute to the risk of cancer recurrence and metastasis. they also point to potential targets for interventions that could reduce this risk. Cancer cells typically are very susceptible to infection. natural oncolytic viruses can be engineered to decrease their ability to infect healthy cells, while still delivering therapeutic payloads to tumors and boosting immune molecules after infection. In a groundbreaking study published in nature, scientists have uncovered a startling biological connection: common respiratory infections such as covid 19 and influenza can awaken dormant breast cancer cells hidden in the lungs. The findings raise big questions for cancer survivors. could a cold or the coronavirus infection quietly trigger cancer’s return? and what role does the immune system play in all of it?.
Common Cold Virus Could Kill Cancer Cells Wordlesstech In a groundbreaking study published in nature, scientists have uncovered a startling biological connection: common respiratory infections such as covid 19 and influenza can awaken dormant breast cancer cells hidden in the lungs. The findings raise big questions for cancer survivors. could a cold or the coronavirus infection quietly trigger cancer’s return? and what role does the immune system play in all of it?. This study suggests that respiratory viruses—including those we might take for granted—could play a hidden role in cancer coming back, especially in the lungs. Pathogens — those bugs that routinely infect and sicken us, like the common cold or influenza — are being studied in labs around the world to see if they can be used safely and effectively to attack and kill cancer cells. What makes this virus stand out is its ability to take over a cell's molecular machinery, including large cellular machines involved in growth, replication and cancer suppression. It’s the first study to demonstrate that such viruses may boost the effectiveness of commonly used cancer therapies by making the cancer cells more vulnerable to the therapies.
Comments are closed.